Rathmell; Richard Edmund

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rathmell; Richard Edmund.The latest application filed is for "5-methyl-1,3,4-oxadiazol-2-yl compounds".

Company Profile

0.9.7

Rathmell; Richard Edmund - Hampshire GB
Rathmell; Richard Edmund - Basingstoke GB
Rathmell; Richard Edmund - Ash Vale GB
Rathmell; Richard Edmund - Avondale GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
5-methyl-1,3,4-oxadiazol-2-yl compounds Grant 10,377,750 - Dreyfus , et al. A	2019-08-13
5-methyl-1,3,4-oxadiazol-2-yl Compounds App 20180339984 - Dreyfus; Nicolas Jacques Francois ; et al.	2018-11-29
6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT.sub.2C receptor agonists Grant 8,680,091 - Briner , et al. March 25, 2	2014-03-25
6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT.sub.2C receptor agonists Grant 8,420,631 - Allen , et al. April 16, 2	2013-04-16
6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS App 20110269745 - BRINER; Karin ; et al.	2011-11-03
6-Arylalkylamino-2,3,4,5-Tetrahydro-1H-Benzo[D]Azepines as 5-Ht2c Receptor Agonists App 20080269196 - Briner; Karin ; et al.	2008-10-30
6-Substituted-2,3,4,5-Tetrahydro-1H-Benzo[D] Azepines as 5-Ht2c Receptro Agonists App 20080207897 - Allen; John Gordon ; et al.	2008-08-28
3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake Grant 7,417,064 - Boulet , et al. August 26, 2	2008-08-26
Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors Grant 7,410,982 - Boulet , et al. August 12, 2	2008-08-12
3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake Grant 7,410,996 - Boulet , et al. August 12, 2	2008-08-12
Heteroaryloxy 3-substituted propanamines as serotonin and norepinephrine reuptake inhibitors Grant 7,037,932 - Gallagher , et al. May 2, 2	2006-05-02
Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors App 20060058360 - Boulet; Serge Louis ; et al.	2006-03-16
3-Aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norephinephrine reuptake App 20060014779 - Boulet; Serge Louis ; et al.	2006-01-19
Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors App 20040176435 - Gallagher, Peter ; et al.	2004-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.